Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth...
by admissionsguy on Sunday September 08, 2024 @04:49PM
(#41483084)
For this reason I have mixed feelings concerning Richard Scolyer’s glioblastoma treatment. On one hand it’s great that he has possibly found something that works and will in time become the new standard of care. At the same time it is disturbing that thousands of patients who are not renowned scientists have to die without a chance to try the same treatment.
[ Parent
| on HN ]
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth...
by melling on Sunday September 08, 2024 @05:30PM
(#41483388)
It is disturbing. For some reason it’s not disturbing enough that we spend more to try and cure these diseases.
The Last Lecture was given almost 20 years ago. Pancreatic cancer is just as deadly today.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth...
by teyc on Sunday September 08, 2024 @05:25PM
(#41483348)
You make a good point. Could there be a case for new ethical considerations to be made. The issue is patients are very vulnerable and no one really knows how bad the downside may be. A prolonged agonising or disabling death can be far worse.